Clinical trial
A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors
NCT03980509
Study timeline
Study start (actual)2020-01-29Date precision: day
Registry last updated2025-01-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
CurcuminDRUG · verified · RxNorm: curcumin
Sponsors & collaborators
Medical University of South Carolinalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03980509 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.